The Japan vaccine market was valued at USD 4.49 Billion in 2025, driven by the introduction of innovative vaccine technologies in the region. The market is anticipated to grow at a CAGR of 8.30% during the forecast period of 2026-2035, with the values likely to reach USD 9.97 Billion by 2035. The increasing government initiatives for vaccine development and Japan's strong healthcare infrastructure are likely to enhance widespread vaccination access and drive market expansion.
Base Year
Historical Period
Forecast Period
In September 2024, Japan approved CSL and Arcturus Therapeutics’s sa-mRNA Covid-19 vaccine, Kostaive, to combat the JN.1 variant. Such regulatory approvals are expected to drive strong growth in the Japan vaccine market.
One of the key trends in the market is the expansion of immunization access. In February 2024, Japanese pharma giant Takeda partnered with Biological E. Limited to scale Qdenga production, aiming for 100 million doses annually by 2030.
Strategic initiatives by leading players to innovate, gain regulatory approvals, and expand into untapped regions are intensifying competition, fueling growth, and solidifying Japan's role as a pivotal market in the global vaccine landscape.
Compound Annual Growth Rate
8.3%
Value in USD Billion
2026-2035
*this image is indicative*
A vaccine is a biological substance that stimulates the immune system to recognize and fight specific pathogens, providing immunity against diseases. The market is driven by increasing awareness, government initiatives, and rising healthcare investments. It is expected to grow due to a high demand for preventive healthcare and advancements in vaccine technology. Japan's aging population further boosts the market’s expansion.
Introduction of Innovative Vaccine Technologies to Boost Market Demand
The introduction of innovative vaccine technologies is poised to drive market growth. For instance, in January 2024, Japan prepared for the launch of ARCT-154, the first fully approved sa-mRNA COVID-19 vaccine. Co-developed by Arcturus Therapeutics and CSL, this vaccine offers safer, scalable production, potentially enhancing Japan's vaccination efforts and accelerating market growth.
The market is witnessing several trends, including expanding regulatory support coupled with a growing emphasis on enhancing vaccine distribution and accessibility.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Disease Indication
Market Breakup by Age
Market Breakup by End User
Segmentation Based on Application to Witness Substantial Growth
By type, the market is divided into subunit vaccines, inactivated, live attenuated, mRNA vaccines, and viral vector vaccines. Among the vaccine types, mRNA vaccines are expected to hold a substantial share of the market. Their rapid development capabilities, high efficacy, and adaptability to emerging variants have positioned them at the forefront of vaccine innovation. Continued investment in research and strong support from regulatory bodies further drive their growth, especially in the context of pandemic preparedness and personalized medicine.
The Japan vaccine market demonstrates strong regional growth, particularly in Eastern and Northern Japan. Eastern Japan, including Tokyo and surrounding prefectures, holds a market share due to advanced healthcare infrastructure and high immunization awareness. Northern Japan shows increasing market demand driven by government initiatives and rising healthcare investments. These regions collectively contribute significantly to the market's expansion and ongoing public health improvements.
The key features of the market report comprise patent analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
GSK (GlaxoSmithKline plc), established in 2000 and headquartered in Brentford, UK, is a leading global biopharmaceutical company. In September 2023, it received approval from Japan’s Ministry of Health, Labour and Welfare for Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults. This vaccine addresses the growing need to protect adults aged 60 and above, particularly those with underlying health conditions. GSK continues to expand its vaccine portfolio in Japan, significantly impacting public health.
Merck & Co., Inc. is a global healthcare leader which was established in 1891. In the Japan vaccine market, Merck plays a key role with its GARDASIL®9 vaccine, which targets HPV-related cancers. In September 2024, the company reported positive Phase 3 trial results for GARDASIL®9 in Japanese males, reinforcing its commitment to addressing HPV-related health concerns in Japan.
Sanofi, headquartered in Paris, France, focuses on transforming medicine with innovative treatments and vaccines. In May 2024, Sanofi entered a co-exclusive licensing agreement with Novavax to commercialize COVID-19 vaccines and develop a flu-COVID-19 combination vaccine. This partnership will enhance access to vaccines in the Japan market, offering broader protection against respiratory diseases.
Pfizer is a leading pharmaceutical company specializing in the development of innovative medicines and vaccines. Notably, Pfizer, in collaboration with BioNTech, has supplied the Omicron XBB.1.5-adapted COVID-19 vaccine (COMIRNATY) to Japan. This vaccine, based on mRNA technology, is pivotal in Japan's 2023 Autumn Special Vaccination Program, showcasing Pfizer's significant role in the Japan vaccine market growth.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include CSL Behring, AstraZeneca plc, and Johnson & Johnson Services, Inc.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Disease Indication |
|
| Breakup by Age |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share